Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
Clinical trial NCT01824602 · TERMINATED
Trial details
- NCT number
- NCT01824602
- Sponsor
- Bial - Portela C S.A.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2006-11-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.